Keyword

burosumab

Description: Burosumab is a monoclonal antibody medicine that inhibits fibroblast growth factor 23 and is used to treat X-linked hypophosphatemia.
Wikidata ID: wiki/Q28209068
OpenAlex ID: keywords/burosumab
2018 · Thomas O. Carpenter, Michael P. Whyte, et al. · New England Journal of Medicine · 521
2019 · Alison Skrinar, Melita Dvorak-Ewell, et al. · Journal of the Endocrine Society · 213
2020 · Suzanne M Jan de Beur, Paul D Miller, et al. · Journal of Bone and Mineral Research · 207
2019 · Michael P Whyte, Thomas O Carpenter, et al. · The Lancet Diabetes & Endocrinology · 202
2020 · Pablo Florenzano, Iris R. Hartley, et al. · Calcified Tissue International · 189
2020 · Rahul Chanchlani, Paul Nemer, et al. · Kidney International Reports · 155
2018 · Yvette N. Lamb · Drugs · 124
2022 · Suzanne M. Jan de Beur, Salvatore Minisola, et al. · Journal of Internal Medicine · 114
2021 · Agnès Linglart, Erik A Imel, et al. · The Journal of Clinical Endocrinology & Metabolism · 111
2020 · Seiji Fukumoto · Journal of Molecular Endocrinology · 104
2020 · Yasuo Imanishi, Nobuaki Ito, et al. · Journal of Bone and Mineral Research · 103
2019 · Anne-Sophie Lambert, Volha Zhukouskaya, et al. · Joint Bone Spine · 91
2021 · Giampiero Igli Baroncelli, Stefano Mora · Frontiers in Endocrinology · 90
2025 · Dieter Haffner, Francesco Emma, et al. · Nature Reviews Nephrology · 86
2022 · Leanne M Ward, Francis H Glorieux, et al. · The Journal of Clinical Endocrinology & Metabolism · 85
2022 · Domenico Rendina, Veronica Abate, et al. · The Journal of Clinical Endocrinology & Metabolism · 83
2019 · Erik A Imel, Andrew Biggin, et al. · JBMR Plus · 79
Works count: 736
Citation count: 7,674
Year
Topic
Type